Stockreport

Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Serina Therapeutics, Inc.  (SER) 
PDF - FDA Grants IND Clearance for SER-252- SER-252 Phase 1b Trial Initiated- Closed Private Placement Financing of up to $30 Million HUNTSVILLE, March 25, 2026 (GLOBE NE [Read more]